Global In-Vitro Toxicology and Toxicity Testing Market Size, Status and Forecast 2024-2031

Report ID: 919999 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Cell Culture Technology
        1.2.3 High Throughput Technologies
        1.2.4 Molecular Imaging Technologies
        1.2.5 Omics Technologies
    1.3 Market by Application
        1.3.1 Global In-Vitro Toxicology and Toxicity Testing Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Pharmaceutical Industry
        1.3.3 Chemical Industry
        1.3.4 Food Industry
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global In-Vitro Toxicology and Toxicity Testing Market Perspective (2016-2027)
    2.2 In-Vitro Toxicology and Toxicity Testing Growth Trends by Regions
        2.2.1 In-Vitro Toxicology and Toxicity Testing Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 In-Vitro Toxicology and Toxicity Testing Historic Market Share by Regions (2016-2021)
        2.2.3 In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Regions (2022-2027)
    2.3 In-Vitro Toxicology and Toxicity Testing Industry Dynamic
        2.3.1 In-Vitro Toxicology and Toxicity Testing Market Trends
        2.3.2 In-Vitro Toxicology and Toxicity Testing Market Drivers
        2.3.3 In-Vitro Toxicology and Toxicity Testing Market Challenges
        2.3.4 In-Vitro Toxicology and Toxicity Testing Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue
        3.1.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue (2016-2021)
        3.1.2 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Players (2016-2021)
    3.2 Global In-Vitro Toxicology and Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by In-Vitro Toxicology and Toxicity Testing Revenue
    3.4 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio
        3.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicology and Toxicity Testing Revenue in 2020
    3.5 In-Vitro Toxicology and Toxicity Testing Key Players Head office and Area Served
    3.6 Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
    3.7 Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 In-Vitro Toxicology and Toxicity Testing Breakdown Data by Type
    4.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Type (2016-2021)
    4.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2022-2027)

5 In-Vitro Toxicology and Toxicity Testing Breakdown Data by Application
    5.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Application (2016-2021)
    5.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
    6.2 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type
        6.2.1 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
        6.2.2 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
        6.2.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
    6.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application
        6.3.1 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
        6.3.2 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
        6.3.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
    6.4 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country
        6.4.1 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021)
        6.4.2 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
    7.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type
        7.2.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
        7.2.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
        7.2.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
    7.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application
        7.3.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
        7.3.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
        7.3.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
    7.4 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country
        7.4.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021)
        7.4.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
    8.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type
        8.2.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
    8.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application
        8.3.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
    8.4 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region
        8.4.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
    9.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type
        9.2.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
        9.2.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
        9.2.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
    9.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application
        9.3.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
        9.3.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
        9.3.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
    9.4 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country
        9.4.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021)
        9.4.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
    10.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type
        10.2.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
    10.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application
        10.3.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
    10.4 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country
        10.4.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GE Healthcare
        11.1.1 GE Healthcare Company Details
        11.1.2 GE Healthcare Business Overview
        11.1.3 GE Healthcare In-Vitro Toxicology and Toxicity Testing Introduction
        11.1.4 GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.1.5 GE Healthcare Recent Development
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Company Details
        11.2.2 Thermo Fisher Scientific Business Overview
        11.2.3 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Introduction
        11.2.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.2.5 Thermo Fisher Scientific Recent Development
    11.3 Bio-Rad Laboratories
        11.3.1 Bio-Rad Laboratories Company Details
        11.3.2 Bio-Rad Laboratories Business Overview
        11.3.3 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Introduction
        11.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.3.5 Bio-Rad Laboratories Recent Development
    11.4 Agilent Technologies
        11.4.1 Agilent Technologies Company Details
        11.4.2 Agilent Technologies Business Overview
        11.4.3 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Introduction
        11.4.4 Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.4.5 Agilent Technologies Recent Development
    11.5 Cyprotex
        11.5.1 Cyprotex Company Details
        11.5.2 Cyprotex Business Overview
        11.5.3 Cyprotex In-Vitro Toxicology and Toxicity Testing Introduction
        11.5.4 Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.5.5 Cyprotex Recent Development
    11.6 Covance
        11.6.1 Covance Company Details
        11.6.2 Covance Business Overview
        11.6.3 Covance In-Vitro Toxicology and Toxicity Testing Introduction
        11.6.4 Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.6.5 Covance Recent Development
    11.7 Bioreliance
        11.7.1 Bioreliance Company Details
        11.7.2 Bioreliance Business Overview
        11.7.3 Bioreliance In-Vitro Toxicology and Toxicity Testing Introduction
        11.7.4 Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.7.5 Bioreliance Recent Development
    11.8 Catalent
        11.8.1 Catalent Company Details
        11.8.2 Catalent Business Overview
        11.8.3 Catalent In-Vitro Toxicology and Toxicity Testing Introduction
        11.8.4 Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.8.5 Catalent Recent Development
    11.9 Charles River Laboratories International
        11.9.1 Charles River Laboratories International Company Details
        11.9.2 Charles River Laboratories International Business Overview
        11.9.3 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Introduction
        11.9.4 Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.9.5 Charles River Laboratories International Recent Development
    11.10 Alere
        11.10.1 Alere Company Details
        11.10.2 Alere Business Overview
        11.10.3 Alere In-Vitro Toxicology and Toxicity Testing Introduction
        11.10.4 Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.10.5 Alere Recent Development
    11.11 Eurofins Scientific
        11.11.1 Eurofins Scientific Company Details
        11.11.2 Eurofins Scientific Business Overview
        11.11.3 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Introduction
        11.11.4 Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.11.5 Eurofins Scientific Recent Development
    11.12 Life Technologies Corporation
        11.12.1 Life Technologies Corporation Company Details
        11.12.2 Life Technologies Corporation Business Overview
        11.12.3 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Introduction
        11.12.4 Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.12.5 Life Technologies Corporation Recent Development
    11.13 Quest Diagnostics
        11.13.1 Quest Diagnostics Company Details
        11.13.2 Quest Diagnostics Business Overview
        11.13.3 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Introduction
        11.13.4 Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
        11.13.5 Quest Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cell Culture Technology
    Table 3. Key Players of High Throughput Technologies
    Table 4. Key Players of Molecular Imaging Technologies
    Table 5. Key Players of Omics Technologies
    Table 6. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global In-Vitro Toxicology and Toxicity Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global In-Vitro Toxicology and Toxicity Testing Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions (2016-2021)
    Table 10. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions (2022-2027)
    Table 12. In-Vitro Toxicology and Toxicity Testing Market Trends
    Table 13. In-Vitro Toxicology and Toxicity Testing Market Drivers
    Table 14. In-Vitro Toxicology and Toxicity Testing Market Challenges
    Table 15. In-Vitro Toxicology and Toxicity Testing Market Restraints
    Table 16. Global In-Vitro Toxicology and Toxicity Testing Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players (2016-2021)
    Table 18. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2020)
    Table 19. Ranking of Global Top In-Vitro Toxicology and Toxicity Testing Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by In-Vitro Toxicology and Toxicity Testing Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
    Table 23. Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2016-2021)
    Table 27. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global In-Vitro Toxicology and Toxicity Testing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application (2016-2021)
    Table 31. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. GE Healthcare Company Details
    Table 64. GE Healthcare Business Overview
    Table 65. GE Healthcare In-Vitro Toxicology and Toxicity Testing Product
    Table 66. GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 67. GE Healthcare Recent Development
    Table 68. Thermo Fisher Scientific Company Details
    Table 69. Thermo Fisher Scientific Business Overview
    Table 70. Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Product
    Table 71. Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 72. Thermo Fisher Scientific Recent Development
    Table 73. Bio-Rad Laboratories Company Details
    Table 74. Bio-Rad Laboratories Business Overview
    Table 75. Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Product
    Table 76. Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 77. Bio-Rad Laboratories Recent Development
    Table 78. Agilent Technologies Company Details
    Table 79. Agilent Technologies Business Overview
    Table 80. Agilent Technologies In-Vitro Toxicology and Toxicity Testing Product
    Table 81. Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 82. Agilent Technologies Recent Development
    Table 83. Cyprotex Company Details
    Table 84. Cyprotex Business Overview
    Table 85. Cyprotex In-Vitro Toxicology and Toxicity Testing Product
    Table 86. Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 87. Cyprotex Recent Development
    Table 88. Covance Company Details
    Table 89. Covance Business Overview
    Table 90. Covance In-Vitro Toxicology and Toxicity Testing Product
    Table 91. Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 92. Covance Recent Development
    Table 93. Bioreliance Company Details
    Table 94. Bioreliance Business Overview
    Table 95. Bioreliance In-Vitro Toxicology and Toxicity Testing Product
    Table 96. Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 97. Bioreliance Recent Development
    Table 98. Catalent Company Details
    Table 99. Catalent Business Overview
    Table 100. Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 101. Catalent Recent Development
    Table 102. Charles River Laboratories International Company Details
    Table 103. Charles River Laboratories International Business Overview
    Table 104. Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Product
    Table 105. Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 106. Charles River Laboratories International Recent Development
    Table 107. Alere Company Details
    Table 108. Alere Business Overview
    Table 109. Alere In-Vitro Toxicology and Toxicity Testing Product
    Table 110. Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 111. Alere Recent Development
    Table 112. Eurofins Scientific Company Details
    Table 113. Eurofins Scientific Business Overview
    Table 114. Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Product
    Table 115. Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 116. Eurofins Scientific Recent Development
    Table 117. Life Technologies Corporation Company Details
    Table 118. Life Technologies Corporation Business Overview
    Table 119. Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Product
    Table 120. Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 121. Life Technologies Corporation Recent Development
    Table 122. Quest Diagnostics Company Details
    Table 123. Quest Diagnostics Business Overview
    Table 124. Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Product
    Table 125. Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
    Table 126. Quest Diagnostics Recent Development
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global In-Vitro Toxicology and Toxicity Testing Market Share by Type: 2020 VS 2027
    Figure 2. Cell Culture Technology Features
    Figure 3. High Throughput Technologies Features
    Figure 4. Molecular Imaging Technologies Features
    Figure 5. Omics Technologies Features
    Figure 6. Global In-Vitro Toxicology and Toxicity Testing Market Share by Application: 2020 VS 2027
    Figure 7. Pharmaceutical Industry Case Studies
    Figure 8. Chemical Industry Case Studies
    Figure 9. Food Industry Case Studies
    Figure 10. Other Case Studies
    Figure 11. In-Vitro Toxicology and Toxicity Testing Report Years Considered
    Figure 12. Global In-Vitro Toxicology and Toxicity Testing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global In-Vitro Toxicology and Toxicity Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions: 2020 VS 2027
    Figure 15. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions (2022-2027)
    Figure 16. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players in 2020
    Figure 17. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by In-Vitro Toxicology and Toxicity Testing Revenue in 2020
    Figure 19. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2016-2021)
    Figure 20. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2022-2027)
    Figure 21. North America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
    Figure 23. North America In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
    Figure 24. North America In-Vitro Toxicology and Toxicity Testing Market Share by Country (2016-2027)
    Figure 25. United States In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
    Figure 29. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
    Figure 30. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Country (2016-2027)
    Figure 31. Germany In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Share by Region (2016-2027)
    Figure 41. China In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
    Figure 49. Latin America In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
    Figure 50. Latin America In-Vitro Toxicology and Toxicity Testing Market Share by Country (2016-2027)
    Figure 51. Mexico In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Share by Country (2016-2027)
    Figure 57. Turkey In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. GE Healthcare Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 61. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 62. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 63. Agilent Technologies Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 64. Cyprotex Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 65. Covance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 66. Bioreliance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 67. Catalent Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 68. Charles River Laboratories International Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 69. Alere Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 70. Eurofins Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 71. Life Technologies Corporation Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 72. Quest Diagnostics Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GE Healthcare
Thermo Fisher Scientific
Bio-Rad Laboratories
Agilent Technologies
Cyprotex
Covance
Bioreliance
Catalent
Charles River Laboratories International
Alere
Eurofins Scientific
Life Technologies Corporation
Quest Diagnostics
Frequently Asked Questions
In-Vitro Toxicology and Toxicity Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
In-Vitro Toxicology and Toxicity Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
In-Vitro Toxicology and Toxicity Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports